05:44 PM EST, 03/08/2024 (MT Newswires) -- Robin Sherrington, Executive Vice President, Strategy & Innovation, on March 07, 2024, sold 7,137 shares in Xenon Pharmaceuticals ( XENE ) for $330,290. Following the Form 4 filing with the SEC, Sherrington has control over a total of 8,398 shares of the company, with 8,398 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1582313/000095017024028795/xslF345X03/ownership.xml